CoChat

Somatic DIS3 mutations in Multiple Myeloma arise early in clonal evolution, but are later counterselected due to toxicity

Kuliński, Tomasz M., Gewartowska, Olga, Mroczek, Seweryn, Szpila, Marcin, Sałas, Katarzyna, Liudkovska, Vladyslava, Dziembowski, Andrzej · 2023
PreprintCited by 4

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

DIS3 encodes an essential ribonucleic subunit of the nuclear exosome complex, responsible for degrading RNA in the nucleus. Somatic DIS3 mutations drive translocations in B cells, leading to multiple myeloma (MM). Clinical data analysis reveals that 42% of DIS3 mutations occur at three recurrent residues (D479, D488, and R780). These mutations, deactivating DIS3 exonucleolytic activity, are never homozygous, often appearing as minor subclones in advanced MM. Surprisingly, mutant DIS3 alleles undergo loss-of-heterozygosity, correlating with frequent del(13q) encompassing DIS3. Overexpression of wild-type DIS3 enhances growth and viability of DIS3-mutated MM cells, while CRISPR-mediated knock-out of the mutant variant, followed by longitudinal co-culture, replicates its elimination through counterselection, observed in the natural course of the disease. In mice, the heterozygous DIS3 D479 mutation is embryolethal, confirming its dominant toxic effects. Transcriptome analysis of patients and cell lines reveals specific transcriptional signatures of DIS3 mutations with accumulation of non-coding unstable RNA species and including secondary indications of decreased proliferation. All these signatures are reversible upon mutant DIS3 loss-of-heterozygosity. DIS3 is an intriguing hit-and-run oncogene that drives MM, but is subsequently eliminated during clonal evolution.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2023.07.27.550471

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 52

  1. 10.1038/nrclinonc.2016.122 · DOI · Paper page
  2. 2017, Multiple myeloma, Nat. Rev. Dis. Prim., 3, 1
  3. 10.3322/caac.21660 · DOI · Paper page
  4. 2019, Multiple Myeloma Genomics-A Concise Review, Narrat. Rev. Acta Medica Acad, 48, 57, 10.5644/ama2006-124.242 · DOI · Paper page
  5. 10.1038/leu.2014.70 · DOI · Paper page
  6. 10.1182/blood-2006-08-040410 · DOI · Paper page
  7. 10.1038/s41375-019-0627-1 · DOI
  8. Ohguchi, Y. & Ohguchi, H . DIS3: The Enigmatic Gene in Multiple Myeloma. International Journal of Molecular Sciences vol. 24 (2023). · DOI
  9. 2011, Initial genome sequencing and analysis of multiple myeloma, Nat. 2011 4717339, 471, 467
  10. 2019, Progress in the identification of gene mutations involved in multiple myeloma, Onco. Targets. Ther., 12, 4075, 10.2147/OTT.S205922 · DOI
  11. Mroczek, S. et al. The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma. Nat. Commun. 8, (2017). · DOI · Paper page
  12. 10.1038/nsmb1184 · DOI · Paper page
  13. 10.1093/nar/gkt930 · DOI · Paper page
  14. 10.1101/gr.189597.115 · DOI · Paper page
  15. 10.1038/nature07480 · DOI · Paper page
  16. 10.1534/genetics.116.187930 · DOI · Paper page
  17. 10.1093/nar/gkv387 · DOI · Paper page
  18. 2022, DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome, Haematologica, 106, 921
  19. 1988, Cold-sensitive and caffeine-supersensitive mutants of the Schizosaccharomyces pombe dis genes implicated in sister chromatid separation during mitosis, EMBO J, 7, 1465, 10.1002/j.1460-2075.1988.tb02964.x · DOI · Paper page
  20. 10.1371/journal.pone.0000317 · DOI · Paper page
  21. 10.1038/s41467-018-02974-x · DOI · Paper page
  22. 10.1101/2023.07.27.550610 · DOI
  23. 10.1038/nri.2016.2 · DOI · Paper page
  24. 10.1016/j.tibs.2020.10.005 · DOI
  25. 10.1016/j.cell.2011.01.001 · DOI · Paper page
  26. 10.1126/sciimmunol.abe8931 · DOI
  27. 10.1016/j.cell.2017.03.043 · DOI · Paper page
  28. 10.1016/j.molcel.2008.02.018 · DOI · Paper page
  29. 10.1371/journal.pone.0131080 · DOI · Paper page
  30. 2019, Leukemia, 33, 2324
  31. 2015, Purification of Eukaryotic Exoribonucleases Following Heterologous Expression in Bacteria and Analysis of Their Biochemical Properties by In Vitro Enzymatic Assays, Methods Mol. Biol., 1259, 417, 10.1007/978-1-4939-2214-7_25 · DOI
  32. 10.1016/B978-0-12-800267-4.00001-8 · DOI · Paper page
  33. 10.1016/B978-0-12-387663-8.00005-3 · DOI
  34. 10.1038/nprot.2016.043 · DOI · Paper page
  35. 10.3324/haematol.2023.283274 · DOI · Paper page
  36. 2021, Noncoding RNA processing by DIS3 regulates chromosomal architecture and somatic hypermutation in B cells, Nat. Genet, 53, 230, 10.1038/s41588-020-00772-0 · DOI · Paper page
  37. 10.15252/embj.2021109700 · DOI · Paper page
  38. 10.1158/0008-5472.BCD-19-0068 · DOI · Paper page
  39. 10.1056/NEJMoa075290 · DOI · Paper page
  40. 2007, RB1 Haploinsufficiency Confers a Proliferation Advantage in Myeloma Cell Lines, Blood, 110, 2489, 10.1182/blood.V110.11.2489.2489 · doi:10.1182/blood.v110.11.2489.2489
  41. 10.1080/10428190600822128 · DOI · Paper page
  42. 10.1182/blood.V98.4.1271 · DOI · Paper page
  43. 10.1016/j.cell.2011.02.013 · DOI · Paper page
  44. Parmigiani, E. , Taylor, V. & Giachino, C . Oncogenic and Tumor-Suppressive Functions of NOTCH Signaling in Glioma. Cells 9, (2020). · DOI
  45. 2022, Notch signaling pathway: architecture, disease, and therapeutics, Signal Transduct. Target. Ther. 2022 71, 7, 1
  46. 10.1038/nrc1186 · DOI · Paper page
  47. 10.1371/journal.pone.0191962 · DOI · Paper page
  48. 2016, Dynamics of CDKN1A in Single Cells Defined by an Endogenous Fluorescent Tagging Toolkit, Cell Rep, 14, 1800, 10.1016/j.celrep.2016.01.045 · DOI · Paper page
  49. Dobin, A. et al. Sequence analysis STAR: ultrafast universal RNA-seq aligner. 29, 15– 21 (2013). · DOI · Paper page
  50. 10.1093/bioinformatics/btr509 · DOI · Paper page
  51. 10.1093/bioinformatics/btq293 · DOI · Paper page
  52. Liao, Y. , Smyth, G. K. & Shi, W . Sequence analysis featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. 30, 923– 930 (2014). · DOI · Paper page

Cited by

See all 4

Metadata

Authors
Kuliński, T. M., Gewartowska, O., Mroczek, S., Szpila, M., Sałas, K., Liudkovska, V., & Dziembowski, A.
Publisher
openRxiv
Published
2023-07-27
Cited by
4
References
10
Type
Preprint

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Somatic DIS3 mutations in Multiple Myeloma arise early in clonal evolution, but are later counterselected due to toxicity. https://app.cochat.ai/papers/10.1101/2023.07.27.550471
The paper
Kuliński, T. M., Gewartowska, O., Mroczek, S., Szpila, M., Sałas, K., Liudkovska, V., & Dziembowski, A. (2023). Somatic DIS3 mutations in Multiple Myeloma arise early in clonal evolution, but are later counterselected due to toxicity. https://doi.org/10.1101/2023.07.27.550471

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.